Cancer

Items 1251-1260 of 2150

per page
Set Descending Direction
  1. Dioscin
    CAS  19057-60-4
    CDX-D0195
    CDX-D0195-M02525 mg
    CHF 231.00
    Dioscin
  2. Diosgenin
    CAS  512-04-9
    CDX-D0536
    CDX-D0536-G02525 g
    CHF 95.00
    CDX-D0536-G100100 g
    CHF 204.00
    Diosgenin
  3. DLK1 (human) (rec.)
    AG-40A-0133
    AG-40A-0133-C01010 µg
    CHF 290.00
  4. DLK1 (human):Fc (human) (rec.)
    AG-40B-0152
    AG-40B-0152-C01010 µg
    CHF 290.00
    Replaces AG-40A-0118
  5. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  6. DLK1, Soluble (human) ELISA Kit
    AG-45A-0032Y
    AG-45A-0032YEK-KI0196 wells
    CHF 610.00
    Standardcurve
  7. DLK2 (human):Fc (human) (rec.)
    AG-40A-0158
    AG-40A-0158-C01010 µg
    CHF 290.00
    AG-40A-0158-C05050 µg
    CHF 830.00
  8. DLL1 (human) (rec.)
    AG-40A-0073
    AG-40A-0073-C01010 µg
    CHF 190.00
    AG-40A-0073-C05050 µg
    CHF 380.00
    Adipogenesis inhibition of MSCs.
MSCs (Mesenchymal stem cells) were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin and glutamine. For differentiation of MSCs, MSCs were cultured in adipogenic medium which was gr
  9. DLL1 (human):Fc (human) (rec.)
    AG-40A-0116Y
    AG-40A-0116Y-C01010 µg
    CHF 305.00
    AG-40A-0116Y-C05050 µg
    CHF 835.00
    Adipogenesis inhibition of 3T3L1 cells.3T3L1 cells were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin. Adipogenesis was initiated by adding 1μM dexamethasone, 0.5mM IBMX, 10μg/ml insulin (day 0) until day
  10. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)

Items 1251-1260 of 2150

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.